Trials / Unknown
UnknownNCT01917799
Aspirin, Heparin and Miscarriage
Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University of Khartoum · Academic / Other
- Sex
- Female
- Age
- 15 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | 75mg tab of LDA once daily for 7 months |
| DRUG | Heparin | 0.4 mL/day of the Enoxaparin |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-11-01
- Completion
- 2013-12-01
- First posted
- 2013-08-07
- Last updated
- 2013-08-07
Locations
1 site across 1 country: Libya
Source: ClinicalTrials.gov record NCT01917799. Inclusion in this directory is not an endorsement.